SCHEMBL13845152

SCHEMBL13845152

O=c1[nH]c2cnc(CC[C@@H]3CCNC3)nc2n1C1CCc2c(Cl)cc(Cl)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 10/20 0.36
JAK3 P52333 10/20 0.36
JAK1 P23458 3/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
PLK4 O00444 1/20 0.30
AURKA O14965 1/20 0.30
DCLK1 O15075 1/20 0.30
PDPK1 O15530 1/20 0.30
ROCK2 O75116 1/20 0.30
RPS6KA5 O75582 1/20 0.30
PRKD3 O94806 1/20 0.30
MAP4K4 O95819 1/20 0.30
PAK4 O96013 1/20 0.30
CHEK2 O96017 1/20 0.30
PRKCG P05129 1/20 0.30
LCK P06239 1/20 0.30
FYN P06241 1/20 0.30
CDK1 P06493 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13608152 0.84 KDM1A (0.40) JAK2JAK3JAK1HTR2AHTR2C
SCHEMBL13608193 0.73 JAK2 (0.41) JAK2JAK3JAK1FGFR1SRC
SCHEMBL13845256 0.69 HRH4 (0.38) JAK2JAK3JAK1TYK2SYK
SCHEMBL12371710 0.65 JAK2 (0.46) JAK2JAK3JAK1MARK3TYK2
SCHEMBL12371773 0.65 JAK2 (0.46) JAK2JAK3JAK1MARK3TYK2
SCHEMBL12371742 0.65 JAK2 (0.46) JAK2JAK3JAK1MARK3TYK2
SCHEMBL12371733 0.65 JAK2 (0.46) JAK2JAK3JAK1MARK3TYK2
SCHEMBL12371745 0.65 JAK2 (0.46) JAK2JAK3JAK1MARK3TYK2
SCHEMBL13608449 0.65 JAK2 (0.46) JAK2JAK3JAK1MARK3TYK2
SCHEMBL13608444 0.64 JAK2 (0.44) JAK2JAK3JAK1TYK2USP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009062059-A2 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PHARMACOPEIA, INC. (US) 2009-05-14 WO disclosed